Canada’s Ongoing Battle Against the Opioid Crisis Ten Years Later

In 2016, the Canadian federal government declared the opioid crisis a public health emergency. Yet, nearly a decade later, the situation remains dire, with thousands of Canadians succumbing to opioid toxicity each year. In response, Health Canada allocated $17 million in late 2025 towards research projects and harm reduction initiatives aimed at preventing substance use. Despite these efforts, stigmatization and negative stereotypes surrounding safe consumption sites pose significant challenges to effective intervention. Notably, Ontario closed nine such sites last year, highlighting the complexities involved in addressing this ongoing crisis.

To explore these issues further, host Maria Kestane spoke with Dimitra Panagiotoglou, the Canada Research Chair in the Economics of Harm Reduction and an associate professor at McGill University. Panagiotoglou’s recent study delves into the relationship between crime associated with supervised consumption sites and public perceptions of substance use. Her insights shed light on how Canadians can engage in more nuanced conversations surrounding this critical public health issue.

Understanding the Impact of Stigmatization

Stigmatization surrounding substance use remains a major barrier to effective harm reduction strategies. These negative perceptions often hinder the establishment and operation of safe consumption sites, which are designed to reduce overdose deaths and provide access to health services. According to Panagiotoglou, addressing this stigma is essential for the success of harm reduction initiatives.

In her research, Panagiotoglou emphasizes the importance of understanding the social dynamics that affect public opinion. She notes that fear and misunderstanding contribute to the negative narratives surrounding these facilities. “People often associate supervised consumption sites with increased crime,” she explains. “However, our research indicates that these sites can actually contribute to safer communities by providing support and reducing harm.”

As part of the $17 million commitment from Health Canada, initiatives aimed at educating the public about the benefits of harm reduction could play a crucial role in changing perceptions. By fostering informed discussions, policymakers and community leaders can work together to create a more supportive environment for those grappling with substance use issues.

Policy Changes and Their Consequences

The closure of nine safe consumption sites in Ontario last year underscores the challenges faced by harm reduction advocates. These closures stemmed from a combination of political decisions and public sentiment, which often leans towards punitive measures rather than supportive ones.

Panagiotoglou argues that the evidence supporting the effectiveness of supervised consumption sites must be communicated more effectively to stakeholders. “We need to emphasize the data that demonstrates reduced overdose deaths in areas with these services,” she states. Such evidence could help shift the narrative and encourage the reopening of closed sites while promoting the establishment of new ones.

The need for comprehensive strategies that include both harm reduction and prevention is clear. With an opioid crisis that continues to escalate, Canada must navigate the complexities of public perception and policy decisions. Engaging in honest and open conversations about substance use can pave the way for meaningful change.

As the nation reflects on ten years since the crisis was first recognized, the emphasis must remain on solutions that prioritize health and well-being over stigmatization. Collaborative efforts among researchers, policymakers, and communities will be essential in tackling the opioid crisis effectively.

Listeners can hear more about this critical topic on The Big Story podcast, where Kestane and her guests continue to explore the intersections of health, policy, and community impact.